Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

NCT01500720 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

179

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Cabazitaxel
DRUG: Topotecan

Sponsor

Sanofi